We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
The Medicines and Healthcare products Regulatory Agency (MHRA) has today (20 December 2024) granted a conditional marketing authorisation for the medicine givinostat (Duvyzat) to treat Duchenne muscular dystrophy (DMD).
Weekly national influenza and COVID-19 report, COVID-19 activity, seasonal flu and other seasonal respiratory illnesses.
Part of a fresh drive to boost the country’s ability to diagnose and test for new and emerging infectious disease threats.
The amended regulatory framework will speed up trial approvals and encourage innovation in trial design without compromising patient safety
The Health and Social Care Secretary made a statement to the House of Commons on puberty-suppressing hormones.
The government has accepted advice from the Joint Committee on Vaccination and Immunisation (JCVI) for the spring 2025 COVID-19 vaccination programme.
Flu positivity jumps to 17.1% as vaccine take-up rates lag behind levels needed to protect the NHS and levels of norovirus highest in a decade for the time of year.
20 new clinical research hubs to be set up across UK to accelerate research into the next generation of treatments.
2024 annual report from Chief Medical Officer, Professor Chris Whitty, focusing on health in cities.
Chronic hepatitis C infections have fallen in people who inject drugs in the last 6 years.
Existing emergency measures banning the sale and supply of puberty-suppressing hormones will be made indefinite, following official advice from medical experts.
The Medicines and Healthcare products Regulatory Agency has approved the medicine delgocitinib (Anzupgo) to treat moderate to severe chronic hand eczema in adults when topical corticosteroids are inadequate or inappropriate.
Health and Social Care Secretary Wes Streeting held a specially-convened meeting with trust leads this morning as the NHS battles record pressures in winter.
Reported notifications of TB in England increased by 11% in 2023 compared to the previous year.
Latest UKHSA data indicates more flu is already circulating this winter compared to last year.
The UK NSC is consulting on whether to offer a human papillomavirus (HPV) self-sampling option to under-screened people in the cervical screening programme.
The pilot scheme, AI Airlock, is designed to help test and improve the rules for AI-powered medical devices to ensure they reach patients quickly, safely and effectively.
UKHSA urges travellers heading abroad to protect against mosquito borne infections
Children with learning or developmental difficulties are at higher risk of exposure to lead.
The purchase will boost the UK’s access to vaccines for a wider range of pathogens of pandemic potential.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).